Market-Moving News for May 21st
$BDRX
$MMAT
$SPT
Biotechnology: Pharmaceutical Preparations
Health Care
Semiconductors
Technology
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/19/2024 | $28.00 | Sector Perform | Scotiabank | |
| 8/22/2024 | $28.00 | Sector Weight → Underweight | KeyBanc Capital Markets | |
| 5/3/2024 | Outperform → Mkt Perform | William Blair | ||
| 5/3/2024 | $80.00 → $44.00 | Buy → Neutral | Goldman | |
| 5/3/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | ||
| 5/3/2024 | $72.00 → $45.00 | Outperform → Neutral | Robert W. Baird | |
| 5/3/2024 | $66.00 → $40.00 | Overweight → Neutral | Piper Sandler | |
| 5/3/2024 | Buy → Neutral | BTIG Research |
Scotiabank initiated coverage of Sprout Social with a rating of Sector Perform and set a new price target of $28.00
KeyBanc Capital Markets downgraded Sprout Social from Sector Weight to Underweight and set a new price target of $28.00
William Blair downgraded Sprout Social from Outperform to Mkt Perform
SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)
SC 13G/A - Biodexa Pharmaceuticals Plc (0001643918) (Subject)
SC 13G - Sprout Social, Inc. (0001517375) (Subject)
424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)
424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)
424B3 - Biodexa Pharmaceuticals Plc (0001643918) (Filer)
CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical needs, has made significant progress in transforming itself from a drug delivery innovator to a therapeutics company with a focus on drugs to fight diabetes and cancer. Biodexa's strategy is not based on discovering new medicines; rather it looks to reduce the risk of failure in the clinic by re-purposing molecules with proven safety records for new indications. When Biodexa sees potential, it acquires these products from third parties under licensing agreements which generally call
CHICAGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sprout Social (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, announced that TrustRadius has recognized their product with a 2025 Buyer's Choice Award. TrustRadius Buyer's Choice Awards are based on vetted, unbiased customer reviews from January 1 to September 26, 2024. During the evaluation process, reviewers are asked if products and their support teams live up to expectations, and if they would buy the product again. These answers shape whether or not a product is chosen as best in the three key areas: capabilities, value for price, and customer relationship. "This recognition reflects our commitmen
November 12, 2024 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Regains Compliance For Continued Listing on Nasdaq Biodexa Pharmaceuticals PLC, (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces that the Company has been formally notified that the Nasdaq Hearings Panel (the "Panel") of the Nasdaq Stock Market LLC ("Nasdaq") determined that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). As previously disclosed, the
CHICAGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. ("Sprout Social", the "Company") (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, today announced the appointment of Mike Wolff to Chief Revenue Officer, effective September 2, 2024. As Chief Revenue Officer, Wolff will oversee Sprout's global Sales, Success and Partnerships organization. He will focus on the continued global growth and expansion of Sprout's innovative offerings. Wolff brings more than 20 years of experience leading global sales and technology organizations. He recently served as Chief Revenue Officer of Salesforce.org, where he led the company's global sales and solu
CHICAGO, June 11, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. ("Sprout Social", the "Company") (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, today announced the appointment of Erika Trautman to chief product officer, effective July 15, 2024. As chief product officer, Trautman will oversee Sprout's global product organization and focus on elevating and expanding Sprout's innovative product offering. Trautman brings more than 15 years of experience in technology to Sprout with a career that has spanned work as a start-up founder to the management of billion-user products. Prior to Sprout, Trautman was the senior vice president and general manag
CHICAGO, March 14, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. ("Sprout Social", the "Company") (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, today announced the appointment of Crystal Boysen to chief people officer (CPO), effective March 25, 2024. As CPO, Boysen will oversee Sprout's global people function and have an essential role in building and elevating Sprout's world-class team. Boysen brings more than 15 years of deep, cross-functional HR experience. Prior to Sprout, Boysen was the CPO at Vimeo where she was responsible for driving a people-first organization and culture, and attracting, engaging and retaining talent globally as the
CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical needs, has made significant progress in transforming itself from a drug delivery innovator to a therapeutics company with a focus on drugs to fight diabetes and cancer. Biodexa's strategy is not based on discovering new medicines; rather it looks to reduce the risk of failure in the clinic by re-purposing molecules with proven safety records for new indications. When Biodexa sees potential, it acquires these products from third parties under licensing agreements which generally call
CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. ("Sprout Social", the "Company") (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its third quarter ended September 30, 2024. "The Sprout team delivered a solid third quarter, driving 20% revenue growth and 31% growth in cRPO as we executed our strategy across key company metrics. Sprout continues to focus on product leadership and expanding our competitive position within the Enterprise segment as these customers leverage the power of Social to drive their digital strategies," said Ryan Barretto, CEO. Third Quarter 2024 Financial Highlights Re
CHICAGO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. ("Sprout Social", the "Company") (NASDAQ:SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the second quarter ending September 30, 2024 after market close on Thursday, November 7, 2024. The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) on Thursday, November 7, 2024. Online registration for this event conference call can be found at https://registrations.events/direct/Q4I1913184. The live webcast of the conference call can be a
Analysts' ratings for Sprout Social (NASDAQ:SPT) over the last quarter vary from bullish to bearish, as provided by 14 analysts. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 4 5 0 0 Last 30D 1 0 0 0 0 1M Ago 0 1 1 0 0 2M Ago 1 0 0 0 0 3M Ago 3 3 4 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $48.07, along with a high estimate of $55.00 and a low estimate of $38.00. Highlighting a 26.05% decrease, the curren
Needham analyst Scott Berg reiterates Sprout Social (NASDAQ:SPT) with a Buy and maintains $55 price target.
4 - Sprout Social, Inc. (0001517375) (Issuer)
4 - Sprout Social, Inc. (0001517375) (Issuer)
4 - Sprout Social, Inc. (0001517375) (Issuer)